Evidence-based Positron Emission Tomography, 1st ed. 2020 Summary of Recent Meta-analyses on PET

This open access book summarizes the findings of recent evidence-based articles (meta-analyses) on the use of positron emission tomography (PET) for various clinical indications. It is divided into five main sections, starting with an introduction to PET and meta-analysis. In turn, the second part addresses evidence-based PET in oncology, providing a broad overview of its use for different types of tumours. The remaining sections are focused on the use of PET in cardiology, in infectious and inflammatory diseases, and in neurology, respectively.

Given its scope and the wealth of information it provides, the book will be an invaluable tool for clinicians with various specialties, as well as international scientific societies interested to the recent evidence-based data about PET.

Section A: Introduction.- 1: Introduction to different PET radiopharmaceuticals and hybrid modalities (PET/CT & PET/MRI).- 2: A practical guideline on diagnostic and prognostic meta-analyses.- Section B: Evidence-based PET in Oncology.- 3: Evidence-based PET for brain and head/neck tumours.- 4: Evidence-based PET for thoracic tumours.- 5: Evidence-based PET for abdominal and pelvic tumours.- 6: Evidence-based PET for cutaneous, musculoskeletal tumours.- 7: Evidence-based PET for haematological tumours.- 8: Evidence-based PET for endocrine tumours and disorders.- Section C: Evidence-based PET in Cardiology.- 9: Evidence-based PET for cardiac diseases.- Section D: Evidence-based PET in Infection & Inflammation.- 10: Evidence-based PET for infectious and inflammatory diseases.- Section E: Evidence-based PET in Neurology.- 11: Evidence-based PET for neurological diseases.

Giorgio Treglia, born in Formia (Italy) in 1979, is currently a Private Docent of  Nuclear Medicine at the Faculty of Biology and Medicine, University of Lausanne (Switzerland), Senior Staff Physician at the Clinic of Nuclear Medicine and PET/CT Centre of the Imaging  Institute of Southern Switzerland, and Head of Research Service and Hospital-based Health Technology Assessment Unit at Ente Ospedaliero Cantonale of Canton Ticino (Switzerland). Furthermore, he is a collaborator of Cochrane Switzerland, a member of the Inflammation & Infection Committee of the European Association of Nuclear Medicine and Molecular Imaging (EANM), and a member of the Faculty of the European School of Molecular Imaging & Therapy (ESMIT). His scientific activities are mainly focused on evidence-based nuclear medicine. He is author or co-author of over 300 articles listed in the PubMed/MEDLINE and Scopus databases, and editor of one book.

Luca Giovanella, born in Verbania (Italy) in 1966, is currently a Titular Professor of Nuclear Medicine at the Faculty of Medicine, University of Zürich (Switzerland), medical and scientific Director of Imaging Institute of Southern Switzerland, Chair of the Clinic of Nuclear Medicine and PET/CT Center and Director of the Competence Centre for Thyroid Diseases at Ente Ospedaliero Cantonale of Canton Ticino (Switzerland). Furthermore, he is currently chair of the Thyroid Committee of the European Association of Nuclear Medicine and Molecular Imaging (EANM), and a member of the Faculty of the European School of Molecular Imaging & Therapy (ESMIT). His scientific activities are mainly focused on nuclear medicine with a special interest on the diagnosis and therapy of thyroid diseases. He is author or co-author of more than 400 articles listed in the PubMed/MEDLINE and Scopus databases, and editor of four books.